Table 2 The two groups' absolute and relative frequency of the CCI at three time-points
Variables | Time 1 * | Time 2 * | Time 3 * | |||
|---|---|---|---|---|---|---|
Comorbidities profile | MMP | UC | MMP | UC | MMP | UC |
Hypertension, no. (%) | 38 (80.8) | 34 (72.3) | 40 (85.1) | 35 (74.5) | 42 (89.4) | 35 (74.5) |
Myocardial infarction, no. (%) | 39 (82.9) | 34 (72.3) | 41 (87.2) | 36 (76.6) | 37 (78.7) | 35 (74.5) |
Diabetes mellitus, no. (%) | 17 (36.1) | 13 (27.7) | 17 (36.1) | 13 (27.7) | 17 (36.1) | 13 (27.7) |
COPD, no. (%) | 10 (21.3) | 13 (27.7) | 10 (21.3) | 13 (27.7) | 10 (21.3) | 13 (27.7) |
Renal disease, no. (%) | 14 (29.8) | 11 (23.4) | 16 (34.0) | 12 (25.5) | 16 (34.0) | 13 (27.7) |
Liver disease, no. (%) | 0 (0) | 1 (2.1) | 0 (0) | 1 (2.1) | 0 (0) | 1 (2.1) |
Peptic ulcers, no. (%) | 25 (53.2) | 24 (51.1) | 34 (72.3) | 32 (68.1) | 36 (76.6) | 32 (68.1) |
Connective tissue disease, no. (%) | 7 (14.9) | 4 (8.5) | 6 (12.8) | 4 (8.5) | 5 (10.6) | 4 (8.5) |
Peripheral vascular disease, no. (%) | 3 (6.4) | 5 (10.6) | 3 (6.4) | 3 (6.4) | 5 (10.6) | 3 (6.4) |
Cancer, no. (%) | 8 (17.1) | 3 (6.4) | 8 (17.1) | 3 (6.4) | 8 (17.1) | 3 (6.4) |
Hemiplegia, no. (%) | 6 (12.8) | 5 (10.6) | 3 (6.4) | 5 (10.6) | 3 (6.4) | 5 (10.6) |
Stroke/ TIA, no. (%) | 4 (8.5) | 8 (17.1) | 5 (10.6) | 8 (17.1) | 5 (10.6) | 9 (19.1) |
Dementia, no. (%) | 3 (6.4) | 1 (2.1) | 1 (2.1) | 2 (4.2) | 1 (2.1) | 1 (2.1) |
Depression, no. (%) | 24 (51.1) | 16 (34.1) | 24 (51.1) | 24 (51.1) | 26 (55.3) | 17 (36.1) |
HIV, no. (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Taking warfarin, no. (%) | 3 (6.4) | 5 (10.6) | 3 (6.4) | 5 (10.6) | 2 (4.2) | 4 (8.5) |